Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07147296Not ApplicableRecruiting

ARC-IM System to Manage Symptomatic Blood Pressure Instability Secondary to Chronic Spinal Cord Injury

Role: lead

NCT06494020Not ApplicableRecruiting

Task Practice and Spinal Cord Stimulation

Role: collaborator

NCT06140706Not ApplicableNot Yet Recruiting

Feasibility of Home Based Transcutaneous Spinal Cord Stimulation for Persons With SCI

Role: collaborator

NCT05941819Not ApplicableUnknown

ARC Therapy to Restore Hemodynamic Stability and Trunk Control in People With Spinal Cord Injury

Role: lead

NCT05284201Not ApplicableCompleted

LIFT Home Study of Non-Invasive ARC Therapy for Spinal Cord Injury

Role: lead

NCT04697472Not ApplicableCompleted

The Up-LIFT Study of Non-Invasive ARC Therapy for Spinal Cord Injury

Role: lead

All 6 trials loaded